


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
ELAN
Elanco Animal Healthorpor
$23.04
Strengths

Upgraded on attractively valued

Trading below its fair value

Earnings are forecast to grow

Investors confidence is positive
Chart
$22.12 (+4.16%)
$18.35 (+25.56%)
$14.64 (+57.38%)
$12.51 (+84.17%)
ELAN has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

ELAN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow
![]()
ELAN Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ELAN Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ELAN current stock price?
What are ELAN stock strengths?
What is ELAN Risk Level?
What is ELAN market cap and volume?
What is ELAN current Stock IQ?
Should I buy ELAN stock right now?
Is ELAN a Strong Buy right now?
What does a 'Strong Buy' rating mean for ELAN?
What does a 'Strong Sell' rating mean for ELAN?
What factors influence ELAN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
ELAN
Elanco Animal Healthorpor
Current Price
$23.04
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value

Earnings are forecast to grow

Investors confidence is positive

Chart
$22.12 (+4.16%)
$18.35 (+25.56%)
$14.64 (+57.38%)
$12.51 (+84.17%)
ELAN Analysts Opinion
ELAN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

Earnings are forecast to grow
![]()
ELAN Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ELAN Street Sentiment is extremely bullish and have positive views on the near-term outlook
ELAN has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
ELAN Latest Analysis
Keybanc Initiates Coverage of Elanco Animal Health (ELAN) with Overweight Recommendation. Fintel reports that on November 21 2025 Keybanc initiated coverage of Elanco Animal Health (NYSE:ELAN) with a Overweight recommendation. Analyst Price Forecast Suggests 15.25% Upside
Fri Nov 21, 2025
Elanco Animal Health Stock Is Undervalued: Analyst. As the pet care industry experiences rapid growth pharmaceutical companies are increasingly focusing on developing innovative treatments for companion animals.ELAN is charging ahead with explosive momentum. ).The company’.s recent Innovation Products launches (Zenrelia and Credelio Quattro) are showing strong revenue growth the analyst said in a note.Analyst Steve Decher expects these and other Innovation Products to continue to drive reve
Fri Nov 21, 2025
Are Options Traders Betting on a Big Move in Elanco Animal Health Stock?. Investors need to pay close attention to ELAN stock based on the movements in the options market lately.
Tue Nov 11, 2025
UBS Maintains Elanco Animal Health (ELAN) Buy Recommendation. Fintel reports that on November 6 2025 UBS maintained coverage of Elanco Animal Health (NYSE:ELAN) with a Buy recommendation. Analyst Price Forecast Suggests 3.87% Upside
Fri Nov 7, 2025
Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates. Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 46.15% and 4.28% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Wed Nov 5, 2025
Elanco Animal Health Q3 Results Top Estimates. Boosts FY25 Outlook . (RTTNews) - Elanco Animal Health Inc. (ELAN) reported Wednesday a net loss of $34 million or $0.07 per share for the third quarter compared to net income of $364 million or $0.73 per share in the prior-year quarter.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ELAN Stock trends
ELAN Stock performance
ELAN Stock analysis
ELAN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.